Leukemia-initiating HSCs in chronic lymphocytic leukemia reveal clonal leukemogenesis and differential drug sensitivity | Zendy

ChiLing Chiang | Zendy; Eileen Hu | Zendy; Lingqian Chang | Zendy; Jadwiga Labanowska | Zendy; Kevan Zapolnik | Zendy; Xiaokui Mo | Zendy; Junfeng Shi | Zendy; Tzyy-Jye Doong | Zendy; Arletta Lozanski | Zendy; Pearlly S. Yan | Zendy; Ralf Bundschuh | Zendy; Logan A. Walker | Zendy; Daniel GallegoPerez | Zendy; Wu Lu | Zendy; Meixiao Long | Zendy; Sanggu Kim | Zendy; Nyla A. Heerema | Zendy; Gerard Lozanski | Zendy; Jennifer A. Woyach | Zendy; John C. Byrd | Zendy; Ly James Lee | Zendy; Natarajan Muthusamy | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Leukemia-initiating HSCs in chronic lymphocytic leukemia reveal clonal leukemogenesis and differential drug sensitivity

Author(s) -

ChiLing Chiang,

Eileen Hu,

Lingqian Chang,

Jadwiga Labanowska,

Kevan Zapolnik,

Xiaokui Mo,

Junfeng Shi,

Tzyy-Jye Doong,

Arletta Lozanski,

Pearlly S. Yan,

Ralf Bundschuh,

Logan A. Walker,

Daniel GallegoPerez,

Wu Lu,

Meixiao Long,

Sanggu Kim,

Nyla A. Heerema,

Gerard Lozanski,

Jennifer A. Woyach,

John C. Byrd,

Ly James Lee,

Natarajan Muthusamy

Publication year - 2022

Publication title -

cell reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.264

H-Index - 154

eISSN - 2639-1856

pISSN - 2211-1247

DOI - 10.1016/j.celrep.2022.111115

Subject(s) - chronic lymphocytic leukemia , fludarabine , cancer research , haematopoiesis , biology , leukemia , myeloid leukemia , myeloid , somatic evolution in cancer , cd38 , vorinostat , stem cell , immunology , microbiology and biotechnology , cd34 , cancer , histone , gene , genetics , chemotherapy , cyclophosphamide , histone deacetylase

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research